[india-drug] Guidelines International Network

["Dr. Hogerzeil" <hogerzeilh@who.int>]

Guidelines International Network
----------------------------------

Dear all,

WHO/EDM and WHO/EURO have become founding members of the new Guidelines
International Network (GIN) . This is a major new international
collaboration involving organisations from around the world.  GIN seeks

to improve the quality of health care by promoting systematic
development of clinical practice guidelines and their application into
practice.  
GIN's aims are:

*	To facilitate information sharing, education and knowledge transfer,
and collaborative working between guideline programmes to promote best
practice and avoid duplication of effort.
*	To improve and harmonise methodologies for systematic guideline
development in existing and new guideline programmes.
*	To improve methodologies for dissemination and implementation of
clinical practice guidelines and evaluation of their effects.
*	To identify priorities for and support research relating to
guideline development, dissemination, implementation, and evaluation;  
and to facilitate the application of research findings into practice.
*	To build links between organisations to improve coordination with
other health care quality initiatives.

So far, about 40 organisations dealing with guideline development and
quality of care from Australia, Austria, Belgium, Canada, Denmark, 
Finland, France, Germany, Ireland, Italy, New Zealand, Norway,
Portugal, Slovenia, Spain, Sweden, Switzerland, Netherlands, UK and USA
have become founding members, at EUR 2500 per year. 

WHO has also become a founding member with the intention to represent 
The global perspective, and especially the developing country
perspective. 

We have also negotiated a limited number of subsidized GIN memberships
for organisations from developing countries. 

If your organisation is interested in joining G-I-N, please contact 
them at:
Guidelines International Network, PO Box 13163, Duns, TD11 3YT, UK. 
Tel: +44.1361.884012, Fax: +44.1361.884013; e-mail:
info@guidelines-international.net. Their website is just open at
(www.guidelines-international.net) but it is still under construction 
and only contains very basic information at present. 

With best regards,

Hans V. Hogerzeil, MD, PhD, FRCP Edin
Coordinator for policy, access and rational use
Department of Essential Drugs and Medicines Policy
World Health Organisation, 1211 Geneva
Tel +41-22-7913528
Fax +41-22-7914167
<hogerzeilh@who.int>



________________________________________________________________________
Missed your favourite TV serial last night? Try the new, Yahoo! TV.
       visit http://in.tv.yahoo.com
The INDIA-DRUG discussion group is a partnership between SATELLIFE
(www.healthnet.org), WHO Essential Drugs and Medicines Policy
(www.who.ch), and the Delhi Society for the Promotion of the
Rational Use of Drugs (DSPRUD) in India.

To send a message to india-drug, write to: india-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe india-drug OR unsubscribe india-drug
To contact a person, send a message to: india-drug-help@healthnet.org